These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1436017)

  • 1. A Bayesian nonparametric approach to analysis of treatment for drug-dependence data.
    Tiwari RC
    NIDA Res Monogr; 1992; 128():70-81. PubMed ID: 1436017
    [No Abstract]   [Full Text] [Related]  

  • 2. Analysis of clinical trials for treatment of opiate dependence: what are the possibilities?
    Jain RB
    NIDA Res Monogr; 1992; 128():116-34; discussion 135-6. PubMed ID: 1436010
    [No Abstract]   [Full Text] [Related]  

  • 3. Three estimators of the probability of opiate use from incomplete data.
    Gross AJ
    NIDA Res Monogr; 1992; 128():82-94; discussion 95-6. PubMed ID: 1436018
    [No Abstract]   [Full Text] [Related]  

  • 4. A Markov model for NIDA data on treatment of opiate dependence.
    Lee ML
    NIDA Res Monogr; 1992; 128():160-7; discussion 168-9. PubMed ID: 1436013
    [No Abstract]   [Full Text] [Related]  

  • 5. Toward a dynamic analysis of disease-state transition monitored by serial clinical laboratory tests.
    Weng TS
    NIDA Res Monogr; 1992; 128():137-57; discussion 158-9. PubMed ID: 1436011
    [No Abstract]   [Full Text] [Related]  

  • 6. Background and design of a controlled clinical trial (ARC 090) for the treatment of opioid dependence.
    Johnson RE; Fudala PJ
    NIDA Res Monogr; 1992; 128():14-24. PubMed ID: 1436012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical treatment of opioid addiction and dependence.
    Ling W; Rawson RA; Compton M
    Methods Mol Med; 2003; 84():285-95. PubMed ID: 12703332
    [No Abstract]   [Full Text] [Related]  

  • 8. [Buprenorphine in the treatment of opiate dependence].
    Auriacombe M; O'Brien CP; Tignol J
    Ann Med Interne (Paris); 1994 Nov; 145 Suppl 3():27. PubMed ID: 7880009
    [No Abstract]   [Full Text] [Related]  

  • 9. [Buprenorphine or methadone for detoxification of young opioid addicts?].
    Ebner R; Schreiber W; Zierer C
    Psychiatr Prax; 2004 Nov; 31 Suppl 1():S108-10. PubMed ID: 15570521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinic-based treatment for opioid dependence: a qualitative inquiry.
    McMurphy S; Shea J; Switzer J; Turner BJ
    Am J Health Behav; 2006; 30(5):544-54. PubMed ID: 16893317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detoxification of opiate addicts with multiple drug abuse: a comparison of buprenorphine vs. methadone.
    Seifert J; Metzner C; Paetzold W; Borsutzky M; Passie T; Rollnik J; Wiese B; Emrich HM; Schneider U
    Pharmacopsychiatry; 2002 Sep; 35(5):159-64. PubMed ID: 12237786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Issues in the analysis of clinical trials for opiate dependence.
    Follmann D; Wu M; Geller N
    NIDA Res Monogr; 1992; 128():97-113; discussion 114-5. PubMed ID: 1436019
    [No Abstract]   [Full Text] [Related]  

  • 13. Mood and affect during detoxification of opiate addicts: a comparison of buprenorphine versus methadone.
    Seifert J; Metzner C; Paetzold W; Borsutzky M; Ohlmeier M; Passie T; Hauser U; Becker H; Wiese B; Emrich H; Schneider U
    Addict Biol; 2005 Jun; 10(2):157-64. PubMed ID: 16191668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sublingual buprenorphine and methadone maintenance treatment: a three-year follow-up of quality of life assessment.
    Giacomuzzi SM; Ertl M; Kemmler G; Riemer Y; Vigl A
    ScientificWorldJournal; 2005 May; 5():452-68. PubMed ID: 15925962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Interactions with methadone and buprenorphine].
    Bakke E; Bachs L
    Tidsskr Nor Laegeforen; 2009 Nov; 129(22):2364-6. PubMed ID: 19935937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Barriers and facilitators to primary care or human immunodeficiency virus clinics providing methadone or buprenorphine for the management of opioid dependence.
    Turner BJ; Laine C; Lin YT; Lynch K
    Arch Intern Med; 2005 Aug 8-22; 165(15):1769-76. PubMed ID: 16087826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment retention in adolescent patients treated with methadone or buprenorphine for opioid dependence: a file review.
    Bell J; Mutch C
    Drug Alcohol Rev; 2006 Mar; 25(2):167-71. PubMed ID: 16627307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concurrent buprenorphine and benzodiazepines use and self-reported opioid toxicity in opioid substitution treatment.
    Nielsen S; Dietze P; Lee N; Dunlop A; Taylor D
    Addiction; 2007 Apr; 102(4):616-22. PubMed ID: 17286641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioid addicts at admission vs. slow-release oral morphine, methadone, and sublingual buprenorphine maintenance treatment participants.
    Giacomuzzi S; Kemmler G; Ertl M; Riemer Y
    Subst Use Misuse; 2006; 41(2):223-44. PubMed ID: 16393744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropsychological functioning of opiate-dependent patients: a nonrandomized comparison of patients preferring either buprenorphine or methadone maintenance treatment.
    Loeber S; Kniest A; Diehl A; Mann K; Croissant B
    Am J Drug Alcohol Abuse; 2008; 34(5):584-93. PubMed ID: 18720267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.